Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HEAD-P

Financiado

Harnessing Evidence on Adverse drug withdrawal events following Deprescribing th...

Harnessing Evidence on Adverse drug withdrawal events following Deprescribing through the Pharmacovigilance system (HEAD-P) Deprescribing (reducing or stopping unnecessary or harmful medications) is an important strategy to reduce the risk of medication harm – a significant and growing challenge for health systems as acknowledged by the World Health Or... ver más

13/10/2026

ROYAL COLLEGE OF S...

216K€

Presupuesto del proyecto: 216K€

Líder del proyecto

ROYAL COLLEGE OF SURGEONS IN IRELAND No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-03

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023 ExpectedOutcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ROYAL COLLEGE OF SURGEONS IN...

215.53K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

WEB-RADR Recognising Adverse Drug Reactions 6M€ Cerrado

ACCESSAFRICA2 Strengthening Clinical Trial Regulatory and Ethical review O... 600K€ Cerrado

EU2P European programme in Pharmacovigilance and Pharmacoepidemio... 8M€ Cerrado

PID2019-109390RB-I00 DETECCION PRECOZ DEL POTENCIAL ADICTIVO DE NUEVAS DROGAS PSI... 121K€ Cerrado

PID2021-128519OB-I00 EVALUACION DE LA SEGURIDAD DE MEDICAMENTOS ANTIHIPERTENSIVOS... 109K€ Cerrado

PID2019-106086RB-I00 VARIABLES PREDICTORAS DEL ABUSO DE OPIOIDES PRESCRITOS EN LO... 109K€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2024-05-03
Fecha Fin: 2026-10-13

Líder del proyecto

ROYAL COLLEGE OF SURGEONS IN IRELAND No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 216K€

Descripción del proyecto Deprescribing (reducing or stopping unnecessary or harmful medications) is an important strategy to reduce the risk of medication harm – a significant and growing challenge for health systems as acknowledged by the World Health Organization. The aim of HEAD-P is to establish the current evidence base on adverse drug withdrawal events (ADWEs) and explore how this can be enhanced via the pharmacovigilance system. HEAD-P consists of 4 research objectives: to assess the rate of ADWEs in published trials of deprescribing; to examine the incidence of adverse events reporting related to ADWEs; to identify and review all recommendations related to the monitoring, detection, and reporting of ADWEs; and to investigate healthcare professional, patient, and policymaker perspectives on the integration of ADWE reporting in the pharmacovigilance system. The following research approaches will be employed: an umbrella review of systematic reviews, disproportionality analysis of key pharmacovigilance databases, a scoping review of sources of guidance, and qualitative semi-structured interviews. This innovative research will help address the significant gap in our knowledge of ADWE occurrence and will stimulate future studies and innovations. Moreover, this fellowship will provide me with valuable scientific (protocol development, quantitative data analysis relevant to pharmacovigilance data, qualitative research methods, data management, and synthesis skills) and transferrable (grant writing, research communication, and supervision and mentoring skills) skills. It will also provide me with valuable international, intersectoral, and interdisciplinary experience, and allow me to develop leaderships skills. The skills and experience I will gain by completing this Fellowship in the host organisation (RCSI), will help me achieve my ultimate career goal – to become a leader in pharmacovigilance research and development in academia or a medicines regulatory agency.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores